Orai1 downregulation impairs lymphocyte function in type 2 diabetes mellitus

Biochemical and Biophysical Research Communications

Volumn 500, Issue 2, 2018, Pages 384-390

  Wang, Haoyang ^a   Wang, Cong ^a   Wang, Limin ^a   Liu, Tiantian ^a   Wang, Zhiqiang ^a   You, Hongjie ^a   Zheng, Yuanyuan ^a   Luo, Dali ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Immune dysfunction; Orai1; Store operated Ca2+ entry

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; INTERLEUKIN 2; STROMAL INTERACTION MOLECULE 1; CALCIUM; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION TEST; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STORE OPERATED CALCIUM ENTRY; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECT; LYMPHOCYTE; METABOLISM; WISTAR RAT;

ANIMALS; CALCIUM; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; GLUCOSE; HUMANS; LYMPHOCYTES; MICE, INBRED C57BL; ORAI1 PROTEIN; RATS, WISTAR;

EID: 85045541584     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2018.04.083     Document Type: Article

References (40)

1. Papagianni, M., Metallidis, S., Tziomalos, K., Herpes zoster and diabetes mellitus: a review. Diabetes Therapy, 2018, 1–6.
2. Martinez, N., Kornfeld, H., Diabetes and immunity to tuberculosis. Eur. J. Immunol. 44 (2014), 617–626.
3. Sefil, F., Ulutas, K.T., Dokuyucu, R., Sumbul, A.T., Yengil, E., Yagiz, A.E., Yula, E., Ustun, I., Gokce, C., Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J. Int. Med. Res., 42, 2014, 581.
4. Jagannathan, M., Mcdonnell, M., Liang, Y., Hasturk, H., Hetzel, J., Rubin, D., Kantarci, A., Dyke, T.E.V., Ganleyleal, L.M., Nikolajczyk, B.S., Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 53 (2010), 1461–1471.
5. Zhang, C., Xiao, C., Wang, P., Xu, W., Zhang, A., Li, Q., Xu, X., The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Hum. Immunol. 75 (2014), 289–296.
6. Shaw, P.J., Feske, S., Physiological and pathophysiological functions of SOCE in the immune system. Frontiers in Bioscience-Landmark 4 (2012), 2253–2268.
7. 2+ entry through Orai is required for transcriptional maturation of the flight circuit in drosophila. J. Neurosci. 35 (2015), 13784–13799.
8. Coudronniere, N., Villalba, M., Englund, N., Altman, A., NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 3394–3399.
9. Lin, X., O'Mahony, A., Mu, Y., Geleziunas, R., Greene, W.C., Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β. Molecular & Cellular Biology, 20, 2000, 2933.
10. Sun, Z., Arendt, C.W., Ellmeier, W., et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature, 404, 2000, 402.
11. Shaw, P.J., Qu, B., Hoth, M., Feske, S., Molecular regulation of CRAC channels and their role in lymphocyte function. Cell. Mol. Life Sci., 70, 2013, 2637.
12. 2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels 7 (2013), 379–391.
13. Desvignes, L., Weidinger, C., Shaw, P., Vaeth, M., Ribierre, T., Liu, M., Fergus, T., Kozhaya, L., Mcvoy, L., Unutmaz, D., STIM1 controls T cell–mediated immune regulation and inflammation in chronic infection. J. Clin. Invest 125:6 (2015), 2347–2362.
14. 2+ entry and T cell-mediated immunity. Nat. Commun., 8, 2017, 14714.
15. 2+ entry in the immune system and beyond. Immunol. Rev. 231 (2009), 189–209.
16. Cousin, M.A., Robinson, P.J., The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci. 24 (2001), 659–665.
17. 2+-NFAT transcriptional signalling in T cell activation and T cell exhaustion. Cell Calcium 63 (2017), 66–69.
18. Crabtree, G.R., Olson, E.N., NFAT signaling: choreographing the social lives of cells. Cell 109 (2002), S67–S79.
19. Feske, S., Müller, J.M., Graf, D., Kroczek, R.A., Dräger, R., Niemeyer, C., Baeuerle, P.A., Peter, H.H., Schlesier, M., Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur. J. Immunol. 26 (1996), 2119–2126.
20. 2+ signals in T lymphocytes. Nat. Immunol. 2 (2008), 316–324.
21. Sanjuan, J., Olivares, J., Identification of a putative regulator of early T cell activation genes. Science 241 (1988), 202–205.
22. Balasubramanyam, M., Premanand, C., Mohan, V., The lymphocyte as a cellular model to study insights into the pathophysiology of diabetes and its complications. Ann. N. Y. Acad. Sci., 958, 2002, 399.
23. 2+ homeostasis. Free Radic. Res. 43 (2009), 138–148.
24. 2+ homeostasis in Type 2 diabetes mellitus. Int. J. Exp. Diabetes Res., 1, 2001, 275.
25. 2+ concentration in lymphocytes and neutrophils of type 2 diabetic patients. Mol. Cell. Biochem. 387 (2014), 251–260.
26. 2+ entry by calsequestrin. Sci. Rep., 5, 2015, 11349.
27. 2+ homeostasis and its association with platelet hyperactivity in diabetes mellitus. Journal of Thrombosis & Haemostasis Jth, 10(1), 2012, 116.
28. 2+ depletion to CRAC channel activation. Nature 454 (2008), 538–542.
29. Covington, E.D., Wu, M.M., Lewis, R.S., Essential role for the CRAC activation domain in store-dependent oligomerization of STIM1. Mol. Biol. Cell 21 (2010), 1897–1907.
30. 2+/calcineurin signalling in cells of the immune system. Biochemical & Biophysical Research Communications 311 (2003), 1117–1132.
31. 2+, calcineurin, and NFAT. Genes & Development 17 (2003), 2205–2232.
32. Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., A mutation in Orai1 causeimmune deficiency by abrogating CRAC channel function. Nature, 441(7090), 2006, 179.
33. 2+ current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J. Biol. Chem. 269 (1994), 32327–32335.
34. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J. Allergy Clin. Immunol. 124 (2009), 1311–1318 e1317.
35. Feske, S., Draeger, R., Peter, H.H., Eichmann, K., Rao, A., The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J. Immunol., 165, 2000, 297.
36. Kim, K.D., Srikanth, S., Yee, M.K.W., Mock, D.C., Lawson, G.W., Gwack, Y., ORAI1 deficiency impairs activated T cell death and enhances T cell survival. J. Immunol. 187 (2011), 3620–3630.
37. Greenberg, M.L., Yu, Y., Leverrier, S., Zhang, S.L., Parker, I., Cahalan, M.D., Orai1 function is essential for T cell homing to lymph nodes. J. Immunol. 190 (2013), 3197–3206.
38. Skrombolas, D., Frelinger, J.G., Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy. Expet Rev. Clin. Immunol. 10:2 (2014), 207–217.
39. Rosalia, R.A., Arenasramirez, N., Bouchaudl, G., Use of enhanced interleukin-2 formulations for improved immunotherapy against cancer. Curr. Opin. Chem. Biol. 23:1 (2014), 39–46.
40. Boyman, O., Kolios, A.G., Raeber, M.E., Modulation of T cell responses by IL-2 and IL-2 complexes. Clin. Exp. Rheumatol., 33(4 Suppl 92), 2015, 54.